MobiHealth News September 14, 2018
Laura Lovett

In the last year the FDA has taken steps to evolve its process for regulating software as a medical device, personal genomics and clinical decision support technology.

In many ways the gatekeepers of healthcare innovation and advancement in the US, the FDA is key in shaping the future of the healthcare industry both in America and abroad. When it comes to the digital space the FDA has been evolving both in the way technology is approved and vetted.

Over the last year FDA Commissioner Scott Gottlieb has put an emphasis on speeding up the process in getting technology and medications out to the public. This is evidenced by the new Pre-Cert program which would uproot the way software as a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Biotechnology, Digital Health, FDA, Govt Agencies, mHealth, Precision Medicine, Regulations, Technology, Wearables
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Share This Article